Literature DB >> 20211886

Biochemical study of a new inhibitor-resistant beta-lactamase, SHV-84, produced by a clinical Escherichia coli strain.

Vera Manageiro, Eugénia Ferreira, Luís Albuquerque, Richard Bonnet, Manuela Caniça.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20211886      PMCID： PMC2863691          DOI： 10.1128/AAC.01442-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  8 in total

1.  Diversity of SHV and TEM beta-lactamases in Klebsiella pneumoniae: gene evolution in Northern Taiwan and two novel beta-lactamases, SHV-25 and SHV-26.

Authors:  F Y Chang; L K Siu; C P Fung; M H Huang; M Ho
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

2.  SHV-49, a novel inhibitor-resistant beta-lactamase in a clinical isolate of Klebsiella pneumoniae.

Authors:  Véronique Dubois; Laurent Poirel; Corinne Arpin; Laure Coulange; Cécile Bebear; Patrice Nordmann; Claudine Quentin
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

3.  Molecular and biochemical characterization of SHV-56, a novel inhibitor-resistant beta-lactamase from Klebsiella pneumoniae.

Authors:  Véronique Dubois; Laurent Poirel; François Demarthe; Corinne Arpin; Laure Coulange; Luciene A R Minarini; Marie-Christine Bezian; Patrice Nordmann; Claudine Quentin
Journal:  Antimicrob Agents Chemother       Date:  2008-07-28       Impact factor: 5.191

4.  Emergence of an inhibitor-resistant beta-lactamase (SHV-10) derived from an SHV-5 variant.

Authors:  E E Prinarakis; V Miriagou; E Tzelepi; M Gazouli; L S Tzouvelekis
Journal:  Antimicrob Agents Chemother       Date:  1997-04       Impact factor: 5.191

5.  Computerized microacidimetric determination of beta lactamase Michaelis-Menten constants.

Authors:  R Labia; J Andrillon; F Le Goffic
Journal:  FEBS Lett       Date:  1973-06-15       Impact factor: 4.124

6.  Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.

Authors:  Nuno Mendonça; Joana Leitão; Vera Manageiro; Eugénia Ferreira; Manuela Caniça
Journal:  Antimicrob Agents Chemother       Date:  2007-03-19       Impact factor: 5.191

7.  Properties of IRT-14 (TEM-45), a newly characterized mutant of TEM-type beta-lactamases.

Authors:  M M Caniça; M Barthélémy; L Gilly; R Labia; R Krishnamoorthy; G Paul
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

8.  The Lys234Arg substitution in the enzyme SHV-72 is a determinant for resistance to clavulanic acid inhibition.

Authors:  Nuno Mendonça; Vera Manageiro; Frédéric Robin; M José Salgado; Eugénia Ferreira; Manuela Caniça; Richard Bonnet
Journal:  Antimicrob Agents Chemother       Date:  2008-03-03       Impact factor: 5.191
  8 in total
  9 in total

1.  In vitro selection of variants resistant to beta-lactams plus beta-lactamase inhibitors in CTX-M beta-lactamases: predicting the in vivo scenario?

Authors:  Aida Ripoll; Fernando Baquero; Angela Novais; Mario J Rodríguez-Domínguez; Maria-Carmen Turrientes; Rafael Cantón; Juan-Carlos Galán
Journal:  Antimicrob Agents Chemother       Date:  2011-07-25       Impact factor: 5.191

2.  Characterization of the inhibitor-resistant SHV β-lactamase SHV-107 in a clinical Klebsiella pneumoniae strain coproducing GES-7 enzyme.

Authors:  Vera Manageiro; Eugénia Ferreira; Antony Cougnoux; Luís Albuquerque; Manuela Caniça; Richard Bonnet
Journal:  Antimicrob Agents Chemother       Date:  2011-11-14       Impact factor: 5.191

3.  Combinatorial active-site variants confer sustained clavulanate resistance in BlaC β-lactamase from Mycobacterium tuberculosis.

Authors:  Philippe Egesborg; Hélène Carlettini; Jordan P Volpato; Nicolas Doucet
Journal:  Protein Sci       Date:  2014-12-30       Impact factor: 6.725

4.  Design and exploration of novel boronic acid inhibitors reveals important interactions with a clavulanic acid-resistant sulfhydryl-variable (SHV) β-lactamase.

Authors:  Marisa L Winkler; Elizabeth A Rodkey; Magdalena A Taracila; Sarah M Drawz; Christopher R Bethel; Krisztina M Papp-Wallace; Kerri M Smith; Yan Xu; Jeffrey R Dwulit-Smith; Chiara Romagnoli; Emilia Caselli; Fabio Prati; Focco van den Akker; Robert A Bonomo
Journal:  J Med Chem       Date:  2013-02-04       Impact factor: 7.446

5.  Substitutions at position 105 in SHV family β-lactamases decrease catalytic efficiency and cause inhibitor resistance.

Authors:  Mei Li; Benjamin C Conklin; Magdalena A Taracila; Rebecca A Hutton; Marion J Skalweit
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

6.  Penam sulfones and β-lactamase inhibition: SA2-13 and the importance of the C2 side chain length and composition.

Authors:  Elizabeth A Rodkey; Marisa L Winkler; Christopher R Bethel; Sundar Ram Reddy Pagadala; John D Buynak; Robert A Bonomo; Focco van den Akker
Journal:  PLoS One       Date:  2014-01-16       Impact factor: 3.240

7.  Outbreak of KPC-2-producing Klebsiella pneumoniae endowed with ceftazidime-avibactam resistance mediated through a VEB-1-mutant (VEB-25), Greece, September to October 2019.

Authors:  Irene Galani; Ilias Karaiskos; Maria Souli; Vassiliki Papoutsaki; Lamprini Galani; Aikaterini Gkoufa; Anastasia Antoniadou; Helen Giamarellou
Journal:  Euro Surveill       Date:  2020-01

Review 8.  Escherichia coli β-Lactamases: What Really Matters.

Authors:  Priyanka Bajaj; Nambram S Singh; Jugsharan S Virdi
Journal:  Front Microbiol       Date:  2016-03-30       Impact factor: 5.640

9.  Detection in two hospitals of transferable ceftazidime-avibactam resistance in Klebsiella pneumoniae due to a novel VEB β-lactamase variant with a Lys234Arg substitution, Greece, 2019.

Authors:  E Voulgari; S D Kotsakis; P Giannopoulou; E Perivolioti; L S Tzouvelekis; V Miriagou
Journal:  Euro Surveill       Date:  2020-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.